Printer Friendly

Intravenous vitamins and minerals for fibromyalgia.

Seven patients with treatment-resistant fibromyalgia, with disease duration of at least eight years, received an intravenous infusion of nutrients once a week for eight weeks. Each infusion contained 400 mg of magnesium chloride hexahydrate, 40 mg of calcium gluconate, 3,000 mg of vitamin C, 1,000 mcg of hydroxocobalamin, 100 mg of pyridoxine hydrochloride, 250 mg of dexpanthenol, 2 mg of riboflavin, 100 mg of thiamine, and 100 mg of niacinamide. The nutrients were administered in 100 ml of normal saline over a period of 20-30 minutes. All patients reported an improvement in pain and fatigue by the second treatment. At the end of the treatment period, there was a 60% reduction in the mean pain severity (p = 0.005) and an 80% decrease in the mean level of fatigue (p = 0.005). No patient reported complete or lasting resolution of pain or fatigue. No side effects were reported.

Comment: In my experience with approximately 30 fibromyalgia patients given a treatment similar to the one described above, some (perhaps 25%) became pain-free (Gaby AR. Altern Med Rev. 2002;7:389-403.). Most of my patients received more magnesium chloride hexahydrate (800 mg vs. 400 mg) and calcium gluconate (200 mg [2 ml of a 10% solution] vs. 40 mg) in their infusion than did those in the present study. In addition, the usual infusion rate for my patients was five to 15 minutes, depending on their tolerance. In contrast, the patients in the present study received the infusion over 20-30 minutes. While there are risks associated with too-rapid infusion of magnesium and other nutrients, the higher peak serum nutrient concentrations that occur with more rapid administration may result in enhanced cellular nutrient uptake and a greater therapeutic effect in some cases.

Massey PB. Reduction of fibromyalgia symptoms through intravenous nutrient therapy: results of a pilot clinical trial. Altern Ther Health Med. 2007;13(3):32-34.
COPYRIGHT 2008 The Townsend Letter Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Literature Review & Commentary
Author:Gaby, Alan R.
Publication:Townsend Letter
Article Type:Brief article
Geographic Code:1USA
Date:Feb 1, 2008
Previous Article:Acetyl-L-carnitine for fibromyalgia.
Next Article:D-ribose for fibromyalgia/chronic fatigue syndrome.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters